- Home
- SSKN vs AEON Comparison
SSKN vs AEON Comparison
Compare SSKN & AEON Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SSKN
- AEON
- Stock Information
- Founded
- SSKN 1989
- AEON N/A
- Country
- SSKN United States
- AEON United States
- Employees
- SSKN N/A
- AEON N/A
- Industry
- SSKN Medical/Dental Instruments
- AEON Biotechnology: Pharmaceutical Preparations
- Sector
- SSKN Health Care
- AEON Health Care
- Exchange
- SSKN Nasdaq
- AEON Nasdaq
- Market Cap
- SSKN 8.9M
- AEON 10.6M
- IPO Year
- SSKN 2005
- AEON N/A
- Fundamental
- Price
- SSKN $1.65
- AEON $0.89
- Analyst Decision
- SSKN Strong Buy
- AEON Strong Buy
- Analyst Count
- SSKN 1
- AEON 1
- Target Price
- SSKN $6.00
- AEON $7.20
- AVG Volume (30 Days)
- SSKN 1.6M
- AEON 258.2K
- Earning Date
- SSKN 11-13-2025
- AEON 11-12-2025
- Dividend Yield
- SSKN N/A
- AEON N/A
- EPS Growth
- SSKN N/A
- AEON N/A
- EPS
- SSKN N/A
- AEON N/A
- Revenue
- SSKN $32,848,000.00
- AEON N/A
- Revenue This Year
- SSKN N/A
- AEON N/A
- Revenue Next Year
- SSKN $9.70
- AEON N/A
- P/E Ratio
- SSKN N/A
- AEON N/A
- Revenue Growth
- SSKN 0.36
- AEON N/A
- 52 Week Low
- SSKN $1.38
- AEON $0.38
- 52 Week High
- SSKN $3.86
- AEON $64.80
- Technical
- Relative Strength Index (RSI)
- SSKN 46.31
- AEON 48.00
- Support Level
- SSKN $1.54
- AEON $0.89
- Resistance Level
- SSKN $1.73
- AEON $1.09
- Average True Range (ATR)
- SSKN 0.17
- AEON 0.07
- MACD
- SSKN -0.00
- AEON -0.01
- Stochastic Oscillator
- SSKN 18.67
- AEON 31.38
About SSKN Strata Skin Sciences Inc.
Strata Skin Sciences Inc is a medical technology company engaged in developing and commercializing products for the treatment of dermatological disorders. Its primary products include the XTRAC excimer laser and VTRAC lamp systems utilized in the treatment of psoriasis, vitiligo and various other skin conditions. Its operating segment includes Dermatology Recurring Procedures, which is the key revenue driver and Dermatology Procedures Equipment. The Dermatology Recurring Procedures segment derives its revenues from the usage of its equipment by dermatologists to perform XTRAC procedures. Its Dermatology Procedures Equipment segment generates revenues from the sale of equipment, such as lasers and lamp products. Geographically, it derives a majority of revenue from the United States.
About AEON AEON Biopharma Inc.
AEON Biopharma Inc is a clinical stage biopharmaceutical company focused on developing of its proprietary botulinum toxin complex ABP-450 (prabotulinumtoxinA) injection for debilitating medical conditions, with an initial focus on the neurosciences market.